You are viewing an incomplete version of our website. Please click to reload the website as full version.

Cytokeratin 1 (KRT1) (pan) antibody

Details for Product No. ABIN145492, Supplier: Login to see
Antigen
  • EpK
  • cytok
  • cytokeratin
  • epi-keratin
  • epiker
  • xK81
Epitope
pan
49
2
1
1
1
1
1
1
1
1
1
Reactivity
Human
90
18
14
10
9
7
7
5
5
5
5
4
3
3
2
2
2
1
1
1
1
1
1
1
Host
Mouse
93
7
4
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
4
3
2
1
1
1
1
1
1
Application
Dot Blot (DB), Immunohistochemistry (Acetone-fixed) (IHC (af)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (IHC), Western Blotting (WB)
58
44
42
34
29
25
21
17
12
2
2
2
1
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen Full length native protein (purified) (Human epidermis).
Clone PCK-26
Isotype IgG1
Specificity PCK-26 recognizes the 58 kDa cytokeratin 5, the 56 kDa cytokeratin 6 and the 52 kDa cytokeratin 8 band in immunoblotting (Lane EB et al). It reacts specifically with a wide variety of normal, reactive and neoplastic epithelial tissues. The antibody reacts with simple, cornifying and non-cornifying squamous epithelia and pseudostratified epithelia. It does not react with non-epithelial normal human tissues.
Cross-Reactivity Mouse (Murine), Cow (Bovine), Goat, Rabbit, Rat (Rattus), Sheep (Ovine)
Purification Ascites.
Alternative Name Cytokeratin (KRT1 Antibody Abstract)
Background Cytokeratins, a group comprising at least 29 different proteins, are characteristic of epithelial and trichocytic cells. Cytokeratin 5, 6 and 8 are members of the type II neutral-to-basic subfamily. Monoclonal antibodies to cytokeratins are specific markers of epithelial cell differentiation and have been widely used as tools in tumor identification and classification. PCK-26 facilitates the typing of normal, metaplastic and neoplastic cells and it may aid in the discrimination of carcinomas and non-epithelial tumors such as sarcomas, lymphomas and neural tumors. It is also useful in detecting micro-metastases in lymph nodes and other tissues and for determining the origin of poorly differentiated tumors (1,2).
Research Area Extracellular Matrix
Pathways
Application Notes AF: Use at an assay dependant dilution. Dot: Use at an assay dependant dilution. IHC-F: Use at an assay dependant dilution. IF: Use at a dilution of 1/300. IHC-P: Use at an assay dependant dilution. IHC-Fr: Use at an assay dependant dilution. WB: Use at an assay dependant dilution. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
Restrictions For Research Use only
Format Liquid
Buffer Ascitic fluid with 0.1% sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid freeze-thaw cycles.
Storage 4 °C
Storage Comment Keep as concentrated solution. Store at 4°C short term. For extended storage aliquot and store at -20°C or below.
Supplier Images
 image for anti-Cytokeratin 1 (KRT1) (pan) antibody (ABIN145492) anti-Cytokeratin 1 (KRT1) (pan) antibody
Immunohistochemistry (IHC) image for anti-Cytokeratin 1 (KRT1) (pan) antibody (ABIN145492) anti-Cytokeratin 1 (KRT1) (pan) antibody (Image 2)
Background publications Moll, Franke, Schiller et al.: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells." in: Cell, Vol. 31, Issue 1, pp. 11-24, 1983 (PubMed).

Lane, Alexander: "Use of keratin antibodies in tumor diagnosis." in: Seminars in cancer biology, Vol. 1, Issue 3, pp. 165-79, 1991 (PubMed).

Lane, Rugg, Navsaria et al.: "A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering." in: Nature, Vol. 356, Issue 6366, pp. 244-6, 1992 (PubMed).